Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-011405·ATWOOD BRIAN G
Schedule 13D ownership disclosure
CERO THERAPEUTICS HLDGS INC
Common Stock, $0.0001 par value per share · CUSIP: 71902K105
Event date: 2025-02-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Atwood-Edminster Trust dtd 4-2-2000
Shares: 196,074.00 · Class: 6.5%
- Brian G. AtwoodReported CIK 0001266567
Shares: 202,404.00 · Class: 6.7%
- Lynne H. Edminster
Shares: 196,074.00 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-011405
- Form type
- SCHEDULE 13D/A
- Filer
- ATWOOD BRIAN G
- CIK
- CIK 1266567
- Filed
- Feb 07, 2025
- Reporting period
- Feb 07, 2025
- Description
- Schedule 13D beneficial ownership